Metabolomic signatures of SSRI exposure during neural differentiation and correlation of lysophosphatidylcholines with early symptoms of neurodevelopmental disorders.
- DOI
- 10.1016/j.ebiom.2026.106291
- Published
- 2026 Jun
- Container
- EBioMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ebiom.2026.106291,
title = {Metabolomic signatures of SSRI exposure during neural differentiation and correlation of lysophosphatidylcholines with early symptoms of neurodevelopmental disorders.},
author = {Arora A and Vacy K and Marques C and Degeratu MO and Mastropasqua F and Humphrey J and Ye X and Oksanen M and Vuillermin P and Ponsonby AL and Lanekoff I and Tammimies K and Barwon Infant Study Investigator Group},
year = {2026},
journal = {EBioMedicine},
doi = {10.1016/j.ebiom.2026.106291},
url = {https://doi.org/10.1016/j.ebiom.2026.106291}
}RIS
TY - JOUR TI - Metabolomic signatures of SSRI exposure during neural differentiation and correlation of lysophosphatidylcholines with early symptoms of neurodevelopmental disorders. AU - Arora A AU - Vacy K AU - Marques C AU - Degeratu MO AU - Mastropasqua F AU - Humphrey J AU - Ye X AU - Oksanen M AU - Vuillermin P AU - Ponsonby AL AU - Lanekoff I AU - Tammimies K AU - Barwon Infant Study Investigator Group PY - 2026 JO - EBioMedicine DO - 10.1016/j.ebiom.2026.106291 UR - https://doi.org/10.1016/j.ebiom.2026.106291 ER -
APA
A, A., K, V., C, M., MO, D., F, M., J, H., X, Y., M, O., P, V., AL, P., I, L., K, T., & Group, B. I. S. I. (2026). Metabolomic signatures of SSRI exposure during neural differentiation and correlation of lysophosphatidylcholines with early symptoms of neurodevelopmental disorders.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2026.106291
Source records
- pubmed · retrieved 2026-09-25T15:16:04.314Z